Genesis Therapeutics

Drug DiscoveryWebsite

Developer of a computational platform designed for the discovery of small-molecule drugs. The company leverages a proprietary molecular artificial intelligence technology that drives the discovery and...

Drug Discovery
Healthcare
Burlingame, CA, United States
Founded 2019
153 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$327.4M
Last Round
Early Stage VC (Series B)
Aug 2023
Latest Funding Round
Early Stage VC (Series B)
Aug 25, 2023
$224M
raised
View all funding rounds
Investors
+22 other investors
View all 22 investors
Valuation History
1 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Genesis Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required